CN110373478A - 数字PCR检测长牡蛎多巴胺-β-羟化酶表达水平的引物及探针 - Google Patents
数字PCR检测长牡蛎多巴胺-β-羟化酶表达水平的引物及探针 Download PDFInfo
- Publication number
- CN110373478A CN110373478A CN201910693602.2A CN201910693602A CN110373478A CN 110373478 A CN110373478 A CN 110373478A CN 201910693602 A CN201910693602 A CN 201910693602A CN 110373478 A CN110373478 A CN 110373478A
- Authority
- CN
- China
- Prior art keywords
- probe
- primer
- digital pcr
- long oyster
- dopamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000523 sample Substances 0.000 title claims abstract description 36
- 241000237502 Ostreidae Species 0.000 title claims abstract description 32
- 235000020636 oyster Nutrition 0.000 title claims abstract description 32
- 102100033156 Dopamine beta-hydroxylase Human genes 0.000 title claims abstract description 21
- 108010015720 Dopamine beta-Hydroxylase Proteins 0.000 title claims abstract description 11
- 239000002253 acid Substances 0.000 claims abstract description 4
- 239000002773 nucleotide Substances 0.000 claims abstract description 4
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 4
- 238000011529 RT qPCR Methods 0.000 abstract description 9
- 210000004698 lymphocyte Anatomy 0.000 abstract description 9
- 238000001514 detection method Methods 0.000 abstract description 7
- 108090000623 proteins and genes Proteins 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 4
- 235000015170 shellfish Nutrition 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 238000011156 evaluation Methods 0.000 abstract description 3
- 230000003862 health status Effects 0.000 abstract description 3
- 238000000034 method Methods 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 101150109673 dbh gene Proteins 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 108060003345 Adrenergic Receptor Proteins 0.000 description 4
- 102000017910 Adrenergic receptor Human genes 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000003943 catecholamines Chemical class 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 210000000087 hemolymph Anatomy 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 229960002748 norepinephrine Drugs 0.000 description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- NOIIUHRQUVNIDD-UHFFFAOYSA-N 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide Chemical compound C=1C=CC=CC=1CNC(=O)CCNNC(=O)C1=CC=NC=C1 NOIIUHRQUVNIDD-UHFFFAOYSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- 241001526627 Azumapecten farreri Species 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 108010021699 I-kappa B Proteins Proteins 0.000 description 1
- 102000008379 I-kappa B Proteins Human genes 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 241000544286 Vibrio anguillarum Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007847 digital PCR Methods 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012772 sequence design Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/124—Animal traits, i.e. production traits, including athletic performance or the like
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开一种数字PCR检测长牡蛎多巴胺‑β‑羟化酶表达水平的引物及探针,所述引物及探针核苷酸序列如下:正向引物:5’‑tggcggaccactctctacatc‑3’;反向引物:5’‑tctccgcgacatcatctgaat‑3’;探针:5’‑cttcttccagctagcgaacgcaacaca‑3’;所述探针添加的荧光基团为6‑羧基荧光素。引物及探针的准确性和特异性高,故可利用数字PCR技术检测长牡蛎血淋巴细胞中NE合成酶CgDBH绝对量的时序变化,以此作为评价养殖长牡蛎健康状况的指标,所建立的评价体系在养殖贝类病害预警预报中具有潜在应用价值。不需要设置对照组,也无需内参基因(Internal control),突破了传统荧光实时定量PCR检测方法的应用局限。
Description
技术领域
本发明属于分子生物学和生物化学技术领域,涉及一种数字PCR检测长牡蛎多巴胺-β-羟化酶表达水平的引物及探针。
背景技术
去甲肾上腺素(Norepinephrine, NE)属于儿茶酚胺类(Catecholamines, CAs)神经递质,是神经内分泌免疫系统中的重要调节分子。NE通过结合免疫细胞胞膜上的肾上腺素能受体(Adrenoceptor,ADR)来调节其免疫应答能力,同时,NE在不同的免疫内环境中结合不同类型的ADRs,产生不同的免疫调节效应。例如,在某些免疫细胞中α2 型肾上腺素能受体能通过 PKC 的活化、IκB 的磷酸化和 NF-κB 的激活,促进 TNF-α、IL-1、IL-6 和 IL-10 的产生和释放;β 型肾上腺素能受体(主要是 β2)通过 cAMP-PKA 通路,来抑制 NF-κB对免疫相关基因的转录。当α2 型肾上腺素能受体和β型肾上腺素能受体都被激活时,β型肾上腺素能受体的作用占优势。
近期的研究发现,贝类是具有完善神经内分泌免疫调节系统的最低等动物,NE在贝类免疫应答中发挥了至关重要的作用。鳗弧菌刺激后,栉孔扇贝血淋巴中NE的浓度显著上升,同时血淋巴细胞中NE合成酶(多巴胺-β-羟化酶,CgDBH)、CfMAO和 CfADR的 mRNA表达水平也显著升高。CfMAO被干扰后,血淋巴细胞中超氧化物歧化酶(CfSOD)的 mRNA 表达水平显著低于对照组。此外,研究发现LPS刺激能够诱导长牡蛎血淋巴细胞合成NE,进而调节血细胞的吞噬活性和凋亡指数。
荧光实时定量PCR(Quantitative real-time PCR,简称qPCR)是用于检测基因mRNA表达水平的经典方法。但此方法只能用于检测基因的相对表达水平,需要设置对照组并选取合适的管家基因作为内参,因此qPCR技术的应用具有很大局限性。相对地,数字PCR是一种核酸分子绝对定量技术,能够直接检出DNA分子的个数,是对起始样品的绝对定量,符合野外调查的需要。但是,迄今为止,没有关于数字PCR检测长牡蛎多巴胺-β-羟化酶表达水平的引物及探针的相关报道,以至于并没有基于数字PCR检测长牡蛎多巴胺-β-羟化酶表达水平的时序变化并以此作为评价养殖长牡蛎健康状况的指标。
发明内容
本发明是为了解决现有技术所存在的上述技术问题,提供一种数字PCR检测长牡蛎多巴胺-β-羟化酶表达水平的引物及探针。
本发明的技术解决方案是:一种数字PCR检测长牡蛎多巴胺-β-羟化酶表达水平的引物及探针,其特征在于所述引物及探针核苷酸序列如下:
正向引物:5’- TGGCGGACCACTCTCTACATC-3’;
反向引物:5’- TCTCCGCGACATCATCTGAAT-3’;
探针:5’- CTTCTTCCAGCTAGCGAACGCAACACA-3’;
所述探针添加的荧光基团为6-羧基荧光素。
本发明设计的数字PCR检测长牡蛎多巴胺-β-羟化酶表达水平的引物及探针的准确性和特异性高,故可利用数字PCR技术检测长牡蛎血淋巴细胞中NE合成酶CgDBH绝对量的时序变化,以此作为评价养殖长牡蛎健康状况的指标,所建立的评价体系在养殖贝类病害预警预报中具有潜在应用价值。不需要设置对照组,也无需内参基因(Internal control),突破了传统荧光实时定量PCR检测方法的应用局限。
附图说明
图1为本发明实施例中长牡蛎CgDBH的qPCR扩增曲线和反应程序图。
图2为本发明实施例中长牡蛎CgDBH的数字PCR反应的质量控制图。
图3本发明实施例不同时期养殖长牡蛎血淋巴细胞中CgDBH基因的绝对表达量图。
具体实施方式
1. CgDBH序列筛查
从长牡蛎基因组中鉴定得到NE合成酶DBH(CgDBH, CGI_10027734)的全长序列,查找其ORF。
2. CgDBH的数字PCR引物和探针设计
利用ThermoFisher公司的Primer Express V3.0软件根据CgDBH的ORF序列设计数字PCR引物和探针。引物及探针核苷酸序列如下:
正向引物:5’- TGGCGGACCACTCTCTACATC-3’;
反向引物:5’- TCTCCGCGACATCATCTGAAT-3’;
探针:5’- CTTCTTCCAGCTAGCGAACGCAACACA-3’;
数字PCR的正向引物长21 bp,GC含量57%,Tm值58.8°C;反向引物长21 bp,GC含量48.0%,Tm值59.2°C;探针长27 bp,GC含量52%,Tm值68.8°C,制备方式为采用HPLC制备,探针添加的荧光基团为6-羧基荧光素(6-FAM)。
实验例1:长牡蛎血淋巴细胞中CgDBH基因绝对表达量的检测
1. 样品收集
用牡蛎刀撬开长牡蛎外壳之后,以10 mL注射器刺破血窦并抽取血淋巴;500目筛绢过滤后加入1.5 mL EP管中,800 g离心10 min,收集血淋巴细胞。
2. 总RNA提取及cDNA文库构建
向每个盛有血淋巴细胞的EP管中加入1 mL Trizol reagent。向每1 mL样品加入200 μL预冷的氯仿(-20℃保存),剧烈震荡3 min,4℃,12,000 g离心15 min。小心吸取上层透明液体400 μL,加入相同体积的预冷异丙醇(-20℃保存),充分混匀后置于-80℃超低温冰箱中自然沉降。10 min后,取出样品,4℃,12,000 g离心15 min。弃去管中液体,加入1 mL 75%无菌乙醇;用手指轻弹起管底沉淀,4℃,12,000 g离心5 min。弃去管中液体,4℃,12,000 g离心30 s,用1 mL注射器小心吸干管底残留液体。开盖静置2~3 min,使乙醇充分挥发干净。每管加入20 μL DEPC水溶解RNA。取微量样品进行核酸电泳以检测RNA质量。 用DNA酶消化混于RNA中的DNA,采用两步法合成cDNA文库第一条链。
3. qPCR法验证数字PCR引物和探针的有效性
利用本发明实施例的数字PCR引物,按照如下反应体系(14.5 μL)进行实验:
qPCR反应程序:50℃ 2 min;95℃ 10 min,95℃ 15,50个循环;60℃ 1 min。
采用7500分析软件,得到Ct值。利用2-ΔΔCt算法得到基因的相对表达水平值。用Excel和SPSS等软件进行统计学分析。
实验结果如图1所示。图1中A为长牡蛎CgDBH的qPCR扩增曲线,B为反应程序图。结果表明:反应进行到约第28轮时检测到FAM基团的荧光信号,且反应进行至约第45轮时达到平台期。该结果说明所设计的用于检测CgDBH绝对表达量的数字PCR引物和探针有效,符合后续实验要求。
实验例2:数字PCR法检测CgDBH基因的绝对表达水平
利用本发明实施例的数字PCR引物及探针,按照如下反应体系(14.5 μL)进行实验:
借助ProFlex™ 2x Flat PCR System (or Dual Flat Block GeneAmp™ PCR System9700)系统,按照如下反应条件:96℃ 10 min(变性),60℃ 2 min(退火并延伸),98℃ 30s,39个循环;60℃ 2 min,10℃ ∞,检测长牡蛎血淋巴细胞中CgDBH基因的绝对拷贝数。
使用QuantStudio™ 3D Digital PCR Instrument系统读取数据,采用QuantStudio™ 3D AnalysisSuite™ Software进行数据分析。利用Excel和SPSS等软件对数据进行统计学分析。
通过对原始数据进行质控分析,结果如图2所示。发现只能检测到特异性的FAM信号的单峰,且FAM阳性信号和ROX阴性对照信号能明显分为两群。结果表明本发明用于检测CgDBH绝对表达量的数字PCR引物和探针具有高度特异性。
实验例3:不同时期养殖长牡蛎血淋巴细胞中CgDBH基因的绝对表达量
应用本发明的数字PCR引物和探针对2019年5月至7月间的长牡蛎血淋巴细胞中CgDBH的 mRNA表达水平进行检测,结果如图3所示。其中,5月份长牡蛎血淋巴细胞中CgDBH的绝对量为12.618个拷贝/微升,而7月份时长牡蛎血淋巴细胞中CgDBH的绝对量为9.545个拷贝/微升,显著低于5月份的水平(p < 0.05) ,出现明显差异。该结果说明利用本发明实施例的引物及探针实施数字PCR,能有效检测养殖长牡蛎体内CgDBH基因的绝对表达水平,从而间接反映养殖长牡蛎的免疫防御能力,相关研究结果在养殖长牡蛎病害预警预报中具有潜在应用价值。
序列表
<110> 大连海洋大学
<120> 数字PCR检测长牡蛎多巴胺-β-羟化酶表达水平的引物及探针
<160> 3
<170> SIPOSequenceListing 1.0
<210> 1
<211> 21
<212> DNA
<213> 人工序列(Artificial)
<220>
<221> misc_feature
<222> (1)..(21)
<400> 1
tggcggacca ctctctacat c 21
<210> 2
<211> 21
<212> DNA
<213> 人工序列(Artificial)
<220>
<221> misc_feature
<222> (1)..(21)
<400> 2
tctccgcgac atcatctgaa t 21
<210> 3
<211> 27
<212> DNA
<213> 人工序列(Artificial)
<220>
<221> misc_feature
<222> (1)..(27)
<400> 3
cttcttccag ctagcgaacg caacaca 27
Claims (1)
1.一种数字PCR检测长牡蛎多巴胺-β-羟化酶表达水平的引物及探针,其特征在于所述引物及探针核苷酸序列如下:
正向引物:5’- TGGCGGACCACTCTCTACATC-3’;
反向引物:5’- TCTCCGCGACATCATCTGAAT-3’;
探针:5’- CTTCTTCCAGCTAGCGAACGCAACACA-3’;
所述探针添加的荧光基团为6-羧基荧光素。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910693602.2A CN110373478A (zh) | 2019-07-30 | 2019-07-30 | 数字PCR检测长牡蛎多巴胺-β-羟化酶表达水平的引物及探针 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910693602.2A CN110373478A (zh) | 2019-07-30 | 2019-07-30 | 数字PCR检测长牡蛎多巴胺-β-羟化酶表达水平的引物及探针 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110373478A true CN110373478A (zh) | 2019-10-25 |
Family
ID=68256935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910693602.2A Pending CN110373478A (zh) | 2019-07-30 | 2019-07-30 | 数字PCR检测长牡蛎多巴胺-β-羟化酶表达水平的引物及探针 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110373478A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104073557A (zh) * | 2014-06-11 | 2014-10-01 | 中国科学院海洋研究所 | 长牡蛎Poly(I:C)应激实验荧光定量的内参基因及其引物和应用 |
CN107488705A (zh) * | 2016-06-12 | 2017-12-19 | 中国检验检疫科学研究院 | 用于水貂源性成分数字pcr精准定量检测的引物探针及方法和试剂盒 |
-
2019
- 2019-07-30 CN CN201910693602.2A patent/CN110373478A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104073557A (zh) * | 2014-06-11 | 2014-10-01 | 中国科学院海洋研究所 | 长牡蛎Poly(I:C)应激实验荧光定量的内参基因及其引物和应用 |
CN107488705A (zh) * | 2016-06-12 | 2017-12-19 | 中国检验检疫科学研究院 | 用于水貂源性成分数字pcr精准定量检测的引物探针及方法和试剂盒 |
Non-Patent Citations (3)
Title |
---|
ZHAOQUN LIU等: "The Cholinergic and Adrenergic Autocrine Signaling Pathway Mediates Immunomodulation in Oyster Crassostrea gigas", 《FRONTIERS IN IMMUNOLOGY》 * |
李伟等: "《分子诊断学》", 30 September 2015, 中国医药科技出版社 * |
杨梅等: "长牡蛎(Crassostrea gigas)Wnt4基因cDNA克隆与表达分析", 《海洋与湖沼》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rosani et al. | Dual analysis of host and pathogen transcriptomes in ostreid herpesvirus 1‐positive C rassostrea gigas | |
Der Sarkissian et al. | Ancient DNA analysis identifies marine mollusc shells as new metagenomic archives of the past | |
Wu et al. | The draft genome of the large yellow croaker reveals well-developed innate immunity | |
Matsushima et al. | MicroRNA signatures in Helicobacter pylori‐infected gastric mucosa | |
WO2015085905A1 (zh) | 沙门氏菌的非编码性rna及其鉴定和应用 | |
Friedman et al. | Validation of a quantitative PCR assay for detection and quantification of ‘Candidatus Xenohaliotis californiensis’ | |
Harl et al. | Geographic and host distribution of haemosporidian parasite lineages from birds of the family Turdidae | |
Aherfi et al. | Marseillevirus in the pharynx of a patient with neurologic disorders | |
Moss et al. | Advanced Perkinsus marinus infections in Crassostrea ariakensis maintained under laboratory conditions | |
CN102816762B (zh) | 一种砗磲科贝类线粒体coi基因扩增引物 | |
Ramilo et al. | Perkinsus olseni and P. chesapeaki detected in a survey of perkinsosis of various clam species in Galicia (NW Spain) using PCR–DGGE as a screening tool | |
Pecher et al. | Assessment of the northern distribution range of selected Perkinsus species in eastern oysters (Crassostrea virginica) and hard clams (Mercenaria mercenaria) with the use of PCR-based detection assays | |
WO2022217125A2 (en) | Isothermal amplification-based detection of shrimp pathogens | |
Davison et al. | Helicobacter cetorum infection in striped dolphin (Stenella coeruleoalba), Atlantic white-sided dolphin (Lagenorhynchus acutus), and short-beaked common dolphin (Delphinus delphus) from the southwest coast of England | |
Liu et al. | Quantitative real-time PCR assay for QPX (Thraustochytriidae), a parasite of the hard clam (Mercenaria mercenaria) | |
CN111850153B (zh) | 检测对虾急性肝胰腺坏死病-副溶血弧菌的引物组及含有该引物组的试剂盒 | |
Bai et al. | RNA-seq of HaHV-1-infected abalones reveals a common transcriptional signature of Malacoherpesviruses | |
JP2021171052A (ja) | チョウザメの性別を同定するためのマイクロrna血清マーカー、プライマーセット、キット及びその使用 | |
CN110373478A (zh) | 数字PCR检测长牡蛎多巴胺-β-羟化酶表达水平的引物及探针 | |
Carrasco et al. | Perkinsus chesapeaki observed in a new host, the European common edible cockle Cerastoderma edule, in the Spanish Mediterranean coast | |
Kim et al. | Urogonimus turdi (Digenea: Leucochloridiidae) from the White’s Thrush, Zoothera aurea, in the Republic of Korea | |
NO20161983A1 (en) | New reovirus infecting rainbow trout | |
Thomas et al. | The ecology and phylogeny of oomycete infections in Asplanchna rotifers | |
Rubin et al. | Differential gene expression in five isolates of the clam pathogen, quahog parasite unknown (qpx) | |
Kang et al. | First report of Perkinsus honshuensis in the variegated carpet shell clam Ruditapes variegatus in Korea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191025 |
|
RJ01 | Rejection of invention patent application after publication |